Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin Fain
G Caleb Alexander

JAMA

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
JAMA|August 21, 2003
Patient-physician communication about out-of-pocket costsG Caleb Alexander, Lawrence P Casalino, David O Meltzer
JAMA|March 22, 2017
Association Between Direct-to-Consumer Advertising and Testosterone Testing and Initiation in the United States, 2009-2013J Bradley Layton, Yoonsang Kim, G Caleb Alexander, et al.
JAMA|July 9, 2026
Formulary-Related Insurance Denials of Single-Source Branded Drugs in the United StatesJoseph F Levy, G Caleb Alexander, Boris Vabson, et al.
JAMA|January 12, 2026
The US Food and Drug Administration's Regulation of MifepristoneSophie Dilek, Joanne Rosen, Anna Levashkevich, et al.
JAMA|February 20, 2019
Assessment of the FDA Risk Evaluation and Mitigation Strategy for Transmucosal Immediate-Release Fentanyl ProductsJeffrey Eric Rollman, James Heyward, Lily Olson, et al.
JAMA|February 7, 2023
Association Between Drug Characteristics and Manufacturer Spending on Direct-to-Consumer AdvertisingMichael J DiStefano, Jenny M Markell, Caroline C Doherty, et al.
JAMA|December 26, 2008
Use of prescription and over-the-counter medications and dietary supplements among older adults in the United StatesDima M Qato, G Caleb Alexander, Rena M Conti, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
JAMA|August 21, 2003
Patient-physician communication about out-of-pocket costsG Caleb Alexander, Lawrence P Casalino, David O Meltzer
JAMA|March 22, 2017
Association Between Direct-to-Consumer Advertising and Testosterone Testing and Initiation in the United States, 2009-2013J Bradley Layton, Yoonsang Kim, G Caleb Alexander, et al.
JAMA|July 9, 2026
Formulary-Related Insurance Denials of Single-Source Branded Drugs in the United StatesJoseph F Levy, G Caleb Alexander, Boris Vabson, et al.
JAMA|January 12, 2026
The US Food and Drug Administration's Regulation of MifepristoneSophie Dilek, Joanne Rosen, Anna Levashkevich, et al.
JAMA|February 20, 2019
Assessment of the FDA Risk Evaluation and Mitigation Strategy for Transmucosal Immediate-Release Fentanyl ProductsJeffrey Eric Rollman, James Heyward, Lily Olson, et al.
JAMA|February 7, 2023
Association Between Drug Characteristics and Manufacturer Spending on Direct-to-Consumer AdvertisingMichael J DiStefano, Jenny M Markell, Caroline C Doherty, et al.
JAMA|December 26, 2008
Use of prescription and over-the-counter medications and dietary supplements among older adults in the United StatesDima M Qato, G Caleb Alexander, Rena M Conti, et al.
Pageof 1